ArticleOncology research2017

Validity of Osteoprotegerin and Receptor Activator of NF-κB Ligand for the Detection of Bone Metastasis in Breast Cancer.

Gamal A Elfar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.